Eltrombopag Powder, For Suspension
Product Images NDC 31722-301
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 31722-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Eltrombopagfororalsuspension125mgfoil (Eltrombopagfororalsuspension125mgfoil)
This is a description of a medication called Eltrombopag for Oral Suspension with a dosage of 12.5 mg. The National Drug Code (NDC) is 31722-300-12. It provides instructions for mixing and usage, including a caution not to use if the packet seal is broken. Additionally, there is a reference to accompanying prescribing information for the usual dosage and a patient information leaflet for reconstitution and use guidance.*
Eltrombopagfororalsuspension125mgoutcarton (Eltrombopagfororalsuspension125mgoutcarton)
This text describes a medication called Eltrombopag for Oral Suspension with a dosage of 12.5 mg per packet. It includes instructions on how to dispense the medication, mixture preparation, and storage guidelines. The medication guide and additional information leaflets are provided for patients. The product is manufactured for Camber Pharmaceuticals. The medication is intended for oral use and should be used following the accompanying prescribing information. The text also provides contact information for more details.*
Eltrombopagfororalsuspension25mgcarton (Eltrombopagfororalsuspension25mgcarton)
This text appears to be prescription information for a medication called Eltrombopag in oral suspension form. It contains details about dosage, storage instructions, and contact information. The medication guide is recommended to be dispensed to each patient separately by the pharmacist. Instructions on mixing and administration are also provided. The medication is manufactured by Canbor Pharmaceutical and is stored at room temperature. Recommended dosage and reconstitution details are included in the prescription information.*
Eltrombopagfororalsuspension25mgfoil (Eltrombopagfororalsuspension25mgfoil)
Eltrombopagfororalsuspension25mgoutcarton (Eltrombopagfororalsuspension25mgoutcarton)
This is a description of Eltrombopag for Oral Suspension, which is a medication that comes in packets for reconstitution. Each packet contains 32 mg of eltrombopag olamine equivalent to 25 mg of eltrombopag free acid. The usual dosage and directions for reconstitution and use can be found in the accompanying prescribing information. The medication guide should be dispensed to each patient separately. The product should be stored at room temperature and any unused liquid should be discarded. For any inquiries or issues, there is a US contact number provided.*
Eltrombopagfororalsuspensioncamberlogo (Eltrombopagfororalsuspensioncamberlogo)
Eltrombopagfororalsuspensiondosingsyringe (Eltrombopagfororalsuspensiondosingsyringe)
Eltrombopagfororalsuspensionfigure1 (Eltrombopagfororalsuspensionfigure1)
Eltrombopagfororalsuspensionfigure2 (Eltrombopagfororalsuspensionfigure2)
Eltrombopagfororalsuspensionfigure3 (Eltrombopagfororalsuspensionfigure3)
Eltrombopagfororalsuspensionfigure4 (Eltrombopagfororalsuspensionfigure4)
Eltrombopagfororalsuspensionfigure5 (Eltrombopagfororalsuspensionfigure5)
Eltrombopagfororalsuspensionfigure6 (Eltrombopagfororalsuspensionfigure6)
Eltrombopagfororalsuspensionfigure7 (Eltrombopagfororalsuspensionfigure7)
Eltrombopagfororalsuspensionmixingbottle (Eltrombopagfororalsuspensionmixingbottle)
Eltrombopagfororalsuspensionpacket (Eltrombopagfororalsuspensionpacket)
Eltrombopagfororalsuspensionstructure (Eltrombopagfororalsuspensionstructure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.